Effect of portal vein embolisation on the growth rate of colorectal liver metastases

[1]  V. Pamecha,et al.  Long-Term Survival and Disease Recurrence Following Portal Vein Embolisation Prior to Major Hepatectomy for Colorectal Metastases , 2009, Annals of Surgical Oncology.

[2]  X. Rogiers,et al.  Major Hepatectomy for Colorectal Metastases: Is Preoperative Portal Occlusion an Oncological Risk Factor? , 2008, Annals of Surgical Oncology.

[3]  W. Scheithauer,et al.  Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Thomas Gruenberger,et al.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.

[5]  D. Gouma,et al.  Risk Assessment of Posthepatectomy Liver Failure Using Hepatobiliary Scintigraphy and CT Volumetry , 2007, Journal of Nuclear Medicine.

[6]  M. Nagino,et al.  Mechanisms of Hepatic Regeneration Following Portal Vein Embolization and Partial Hepatectomy: A Review , 2007, World Journal of Surgery.

[7]  Theo Wobbes,et al.  Outgrowth of human liver metastases after resection of the primary colorectal tumor: A shift in the balance between apoptosis and proliferation , 2006, International journal of cancer.

[8]  M. Makuuchi,et al.  Expression of Transforming Growth Factor-α and -β in Hepatic Lobes After Hemihepatic Portal Vein Embolization , 2006, Digestive Diseases and Sciences.

[9]  R. Hutchins,et al.  Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. , 2006, The British journal of radiology.

[10]  O. Garden,et al.  Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies , 2006, British Journal of Cancer.

[11]  J. Berlin,et al.  Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S J Wigmore,et al.  The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection , 2005, Gut.

[13]  X. Rogiers,et al.  Sustained function in atrophying liver tissue after portal branch ligation in the rat. , 2003, The Journal of surgical research.

[14]  T. Muto,et al.  Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization , 2001, Hepatology.

[15]  P. Bachellier,et al.  Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? , 2001, American journal of surgery.

[16]  E. Abdalla,et al.  Portal vein embolization: rationale, technique and future prospects , 2001, The British journal of surgery.

[17]  T. Tsuji,et al.  Different expression of positive and negative regulators of hepatocyte growth in growing and shrinking hepatic lobes after portal vein branch ligation in rats. , 2000, International journal of molecular medicine.

[18]  T. de Baère,et al.  During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma , 1999, The British journal of surgery.

[19]  M. Nagino,et al.  Immediate increase in arterial blood flow in embolized hepatic segments after portal vein embolization: CT demonstration. , 1998, AJR. American journal of roentgenology.

[20]  J. Going,et al.  Efficiently estimated histologic cell counts. , 1994, Human pathology.

[21]  B. Gray,et al.  Vascularization of small liver metastases , 1989, The British journal of surgery.

[22]  G I Bell,et al.  Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Parks,et al.  Perioperative chemotherapy with FOLFOX 4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer ( EORTC Intergroup trial 40983 ) : a randomised controlled trial , 2008 .

[24]  M. Makuuchi,et al.  Expression of transforming growth factor-alpha and -beta in hepatic lobes after hemihepatic portal vein embolization. , 2006, Digestive diseases and sciences.

[25]  J. Melendez,et al.  Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. , 2001, Journal of the American College of Surgeons.

[26]  V. Vilgrain,et al.  Intrahepatic hemodynamic changes following portal vein embolization: a prospective Doppler study , 2000, European Radiology.

[27]  T. Inoue,et al.  Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells. , 1998, International journal of cancer.

[28]  T. Aikou,et al.  Exogenous hepatocyte growth factor markedly stimulates liver regeneration following portal branch ligation in dogs , 1996, Cancer Chemotherapy and Pharmacology.